Building a reliable TB laboratory EQA participation protocol
External quality assessment (EQA) gives a tuberculosis laboratory an independent check on whether its testing is accurate, consistent and clinically useful. A well-designed protocol turns participation from a once-a-year compliance task into a controlled part of the laboratory quality management system.
For laboratories across Australia, the protocol must work in very different settings: a large metropolitan service in Sydney or Melbourne, a regional hospital in Queensland, or a small facility supporting patients in the Northern Territory. It should define what staff do before, during and after an EQA round, while fitting local accreditation expectations, transport conditions and available resources.
Define the purpose and scope
Start by stating why the laboratory participates in an EQA scheme. The purpose may include monitoring the accuracy of smear microscopy, nucleic acid amplification testing, culture, identification, drug susceptibility testing or rapid molecular detection of resistance. The protocol should specify which methods, instruments, specimen types and staff groups are included.
A clear scope prevents gaps. For example, a laboratory may enrol its GeneXpert or other molecular platform but overlook microscopy performed at a satellite site. It should identify every testing location, relevant assay, instrument model and reporting pathway. If several facilities share a service, explain whether each site receives samples separately or whether one central laboratory coordinates the response.
The protocol should also state which EQA provider or reference laboratory is used, how often rounds occur and who authorises participation. In Australia, laboratories may need to align the arrangement with National Association of Testing Authorities (NATA) accreditation under ISO 15189, state or territory health department requirements, and the conditions of the particular scheme. Record the scheme name, enrolment status, contact details and renewal date in a controlled document.
A practical quality framework can help connect EQA activity with other laboratory processes. The quality management roadmap is useful for placing external assessment alongside personnel, equipment, documentation, safety and continual improvement activities.
Assign responsibilities before the round
An EQA protocol should name people by role rather than relying on informal knowledge. The laboratory manager or quality manager may maintain enrolment, while a senior scientist or authorised medical laboratory scientist coordinates the technical work. The document should also identify who receives the samples, checks the package, performs testing, reviews results and approves the final submission.
Include a deputy for every critical role. Staff leave, roster changes and public holidays can easily cause a deadline to be missed, particularly in a small regional service. In a hospital laboratory, the duty scientist may need a brief handover note explaining where EQA materials are stored, which worksheet is required and who can release the final response.
Staff must understand that EQA material is handled in the same controlled manner as patient material unless the provider gives different instructions. Training should cover sample identification, biosafety, test selection, result interpretation and electronic submission. Competency records can include observation, review of worksheets and discussion of unexpected findings.
The protocol should prohibit informal result sharing before the submission deadline. Comparing answers with another laboratory may compromise the assessment and prevent the service from identifying its own process weaknesses. Technical consultation is appropriate when an instruction is unclear, but it should be documented and directed through the provider’s approved channel.
Control receipt, storage and testing
Receipt is the first operational checkpoint. The assigned staff member should record the delivery date, package condition, temperature indicators if supplied, sample identifiers, number of items and any visible leakage or damage. Photographing damaged packaging may support a query to the provider, provided patient or scheme confidentiality is maintained.
Storage instructions should be explicit. State the required temperature, restricted-access location, maximum holding time and action to take if conditions are outside specification. A remote service in Western Australia or the Northern Territory may face long freight routes, aircraft delays and limited courier schedules. The protocol should explain how staff protect sample integrity and notify the provider when transport conditions could affect testing.
Testing must follow the laboratory’s routine approved procedure. Staff should not create a special process simply to achieve a favourable EQA result. Record the instrument identification, reagent or kit lot, operator, date and time, controls, run validity and any repeat testing. If a result is repeated, document the reason and retain the original outcome rather than replacing it without explanation.
Where the scheme permits more than one test, define the decision rules in advance. For example, a laboratory may use a molecular assay first and refer selected material for culture or susceptibility testing. The protocol should explain how discrepant results are investigated and which result is submitted. Results must be checked against the provider’s units, coding system and reporting format before release.
Manage submission and confidentiality
Create a simple submission checklist that covers every required field. It may include sample identification, qualitative interpretation, quantitative value, resistance marker, comments, operator details and test date. A second authorised person should verify transcription from the worksheet or instrument report to the electronic portal.
Deadlines need special attention. Enter the closing date and local time in the laboratory calendar, with an earlier internal deadline allowing for review. If the portal is unavailable, the designated coordinator should contact the provider and retain evidence of the outage. Do not wait until the final afternoon, when a network problem in Brisbane or a delayed approval from a central office can leave no practical recovery time.
Confidentiality controls should cover scheme passwords, reports, worksheets and communications. Store records in the laboratory’s controlled document or quality system repository, not in personal email folders. Limit access to staff who need it, and follow organisational cybersecurity and records-retention policies.
The protocol should state who can approve the submission. For high-risk tests, such as rifampicin or multidrug-resistant TB detection, the reviewer should confirm that the submitted interpretation matches the technical result and local reporting rules. Any amendment after submission must be traceable, justified and communicated to the EQA provider.
Review outcomes and investigate failures
When the provider returns a report, the quality coordinator should log the outcome and distribute it to relevant staff. Review more than the pass or fail status. Examine individual items, trends across rounds, peer-group performance, comments from the provider and any difference between routine patient testing and EQA performance.
Define a trigger for investigation. Examples include an unacceptable result, a late submission, an omitted item, an invalid run, a transcription error or a result that is technically correct but poorly interpreted. A single unexpected result may reflect a specimen characteristic, while repeated errors may indicate a problem with training, equipment, reagent storage or the reporting interface.
Use a structured root-cause analysis rather than assigning blame. Ask whether the issue arose during receipt, storage, preparation, testing, interpretation, transcription or review. In a busy public hospital, the cause may be a roster gap; in a remote clinic, it may be unstable refrigeration or freight timing. The response should match the cause.
Corrective action might include repeating competency assessment, revising a worksheet, servicing equipment, checking calibration, changing stock rotation, updating a standard operating procedure or arranging technical advice from a reference laboratory. Assign an owner and due date for each action. The quality manager should verify effectiveness, for example by reviewing the next EQA round, internal quality control or targeted case review.
Use EQA data for continual improvement
EQA results become more valuable when combined with internal quality indicators. Track participation rate, on-time submissions, unacceptable results, invalid tests, repeat testing, corrective-action completion and recurring error types. Review the data at a quality meeting and escalate significant risks through the laboratory’s governance structure.
A visual display can make trends easier to notice across a central laboratory and its satellite services. The practical visual metrics guide describes a way to present quality measures clearly without turning the board into a cluttered collection of numbers. Only use de-identified, authorised information, especially where small teams could make individual performance recognisable.
Set review intervals in the protocol. A monthly check may suit active molecular testing, while a quarterly review could be adequate for a low-volume service. Include an annual evaluation of the EQA scheme itself: whether the scope remains appropriate, whether samples reflect the laboratory’s work, whether reports are timely and whether staff can complete the process reliably.
Australian services should also consider geographic and operational resilience. A laboratory in Darwin may need a contingency for wet-season transport disruption, while a metropolitan service may need a plan for instrument downtime or a surge in respiratory testing. Agreements with a nearby public laboratory, state reference service or approved referral pathway should be documented before an urgent problem occurs.
Finally, review the protocol after every major change in assay, instrument, EQA provider, staffing model, accreditation requirement or specimen transport arrangement. Keep the current version available at the point of use, withdraw obsolete copies and record staff acknowledgement. A protocol that is brief, owned and regularly tested is more useful than a detailed document that nobody follows.
Adopt the protocol as a controlled quality document, assign the roles, register the next EQA round and run the first receipt-to-review cycle against the checklist. Use the findings to strengthen your TB testing service, support accreditation evidence and ensure that accurate results reach patients and clinicians wherever care is delivered across Australia.